Fulcrum Therapeutics Inc (FULC)
Healthcare
Biotechnology
3.70 $
+3.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Fulcrum Therapeutics Inc (FULC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -60 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -20 | -23 | -39 | -54 | -78 | -97 | -91 | -2.2 | -60 | |
| 0.7 | 1.3 | 2.1 | 2.4 | 2.5 | 2.4 | 2.2 | 1.6 | 1.4 | |
| 1.4 | 2.2 | 4.2 | 7.4 | 11 | 13 | 15 | 15 | 12 | |
| 1.4 | 2.2 | 30 | 7.4 | 11 | 13 | – | – | – | |
| 0.8 | 6.5 | 11 | 7.5 | -12 | -3.1 | -4.6 | -4.2 | 3.9 | |
| 1.9 | 9.0 | 0.9 | 1.3 | 1.7 | 2.0 | 0.5 | 0.3 | 0.3 | |
| -1.9 | -9.0 | -0.9 | -57 | -130 | 12 | -37 | 32 | 31 | |
| 0.0 | 0.0 | – | 69 | – | – | – | – | – | |
| 18 | 105 | 0.0 | -0.2 | 3.7 | -0.2 | – | – | – | |
| -0.1 | -0.1 | 0.0 | -0.1 | 0.0 | -0.1 | – | – | – | |
| 18 | 105 | 64 | 71 | 187 | 84 | 118 | 2.7 | 169 | |
| -4.3 | 73 | 24 | -40 | -22 | -0.3 | -9.5 | 33 | 139 | |
| -22 | -32 | -40 | -55 | -80 | -99 | -91 | -2.5 | -60 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.